241820 — PCL Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- KR₩18bn
- KR₩26bn
- KR₩1bn
Annual balance sheet for PCL, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,179 | 38,222 | 32,466 | 6,398 | 3,352 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 705 | 1,774 | 7,512 | 10,248 | 3,286 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 35,959 | 63,744 | 58,625 | 31,854 | 7,785 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,905 | 14,137 | 14,725 | 9,463 | 1,578 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 43,560 | 79,295 | 87,938 | 62,194 | 21,577 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6,046 | 46,267 | 48,290 | 20,603 | 11,117 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 6,810 | 64,746 | 56,380 | 26,703 | 14,460 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 36,749 | 14,549 | 31,558 | 35,491 | 7,116 |
Total Liabilities & Shareholders' Equity | 43,560 | 79,295 | 87,938 | 62,194 | 21,577 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |